We will be attending BIO-Europe Spring 2025, a renowned partnering event uniting global life science leaders. With 3,700+ participants, it offers unmatched opportunities to exchange insights, explore trends, and foster strategic connections across the innovation ecosystem.

We will attend Swiss Biotech Day 2026, Switzerland’s leading life sciences conference. Bringing together biotech, pharma, investors, regulators, and innovation enablers, the event offers a high-density partnering environment focused on R&D translation, manufacturing, and international collaboration. It is a key forum to engage with decision-makers shaping Europe’s biotech competitiveness.

We will take part in SciComPt2026, Portugal’s national meeting dedicated to science communication professionals, researchers, and institutions. The event explores evidence-based communication strategies, public engagement, and the role of digital channels in translating scientific knowledge, aligning closely with Magma Science’s mission to elevate life sciences visibility through rigorous, strategic communication.

Designed to accelerate collaboration across the Portuguese biotech landscape, BioMeet 2026 convenes startups, scale-ups, academia, investors, and industry leaders for targeted networking and knowledge exchange. With a strong emphasis on innovation pipelines, funding pathways, and industry–academia synergies, BioMeet provides a relevant platform to engage with emerging biotech projects and ecosystem builders.

Returning to Lisbon in 2026, PEGS Europe remains one of Europe’s most influential conferences in protein and antibody engineering. Organised by CHI, PEGS Europe brings together senior scientists, technology developers, and biopharma leaders to discuss advances in biologics discovery, engineering, and development. Magma Science will attend to connect with organisations driving next-generation biologics and complex scientific innovation.

Date and place have yet to be confirmed.